News

News
Partner news

Teneobio Announces Achievement of Milestone Payment as Janssen Advances Phase I Study of Bispecific JNJ-75348780 for the Treatment of NHL and CLL

Read full story
Partner news

Cidara Therapeutics Announces Agreement with Janssen to Develop and Commercialize AVCs for the Prevention and Treatment of Influenza

Read full story
Partner news

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Read full story
Partner news

Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement

Read full story
JNJ Press releases

Gathering Innovation Strength to Capture New Value Johnson & Johnson is Recognized as the First Foreign-Funded Open Innovation Platform by the Shanghai Municipal Government

Read full story
Partner news

Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen

Read full story
Partner news

£10 million research collaboration to detect lung cancer earlier

Read full story
Partner news

Revitope Oncology Announces Strategic Collaboration with Janssen to Leverage its Unique T Cell Engager Platform

Read full story
Partner news

Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program

Read full story
Partner news

MacroGenics Enters Research Collaboration with Janssen to Develop Novel DART® Molecule

Read full story
Partner news

Australian National University Announces Research Project with Janssen to Help Develop New Methods for Measuring and Monitoring Type 1 Diabetes

Read full story
Partner news

Symvivo Corporation Announces Research Agreement with Janssen to Offer Novel Approach to Therapeutic Protein Delivery

Read full story
Partner news

CHO Plus Announces Research Collaboration Agreement with Janssen to Improve Manufacturing of Therapeutic Proteins

Read full story
Partner news

UK Biobank launches one of the largest scientific studies measuring circulating proteins, to better understand the link between genetics and human disease

Read full story
Partner news

Xencor Enters Collaboration with Janssen with Aim to Discover Novel CD28 Bispecific Antibodies for the Treatment of Prostate Cancer

Read full story